That is the GDL Way

Utilizing cutting edge genetic technologies, our tests can provide a better understanding of patient’s reactions to drugs and help avoid adverse drug events while enhanc-ing the efficacy of treatments.

  • Nearly every pathway of drug metabolism, transport, and action is susceptible to genetic influence and varia-tions. It is estimated that up to 95% of an individual’s variation in drug response is based on genetics.
  • For many healthcare providers genetics remains a ma-jor unknown in most therapies. This can result in ADEs, in addition to a reduction in treatment efficacy.

This form of testing provides information on the highly polymorphic cytochromes responsible for drug metabo-lism and enables physicians to: 

  • Individualize patient therapies
  • Optimizing the safety and efficacy of prescription regimens
  • Improve treatment compliance, especially in patients requiring long-term or multi-drug therapy
  • Keep their practice current with the latest advances in genetic science

Drug metabolism genetic testing empowers the physician to assess drug efficacy as well as safety for a patient prior to initiation of therapy.